What is Vildagliptin?

Category: Prescription Drugs

Most popular types: Galvus Jalra


See also: Metformin-vildagliptin

Vildagliptin is an international antidiabetic agent use in the treatment of noninsulin dependent diabetes as an adjunct to diet and exercise as a single agent or in combination therapy with other antidiabetic agents.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with Vildagliptin

Side effect Patients


Based on patients currently taking Vildagliptin

Dosage Patients
50 mg daily 1

Why patients stopped taking Vildagliptin

Multiple reasons could be selected

Reason Patients
Doctor's advice 1
See 1 patient who's stopped taking Vildagliptin


Currently taking Vildagliptin

Duration Patients
1 - 2 years 1

Stopped taking Vildagliptin

Duration Patients
2 - 5 years 1
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1

What people switch to and from

Patients started taking Vildagliptin after stopping:

Treatment Patients
Metformin (Metformin ER) 1

Patients stopped taking Vildagliptin and switched to:

Treatment Patients
Metformin-vildagliptin (Galvus Met) 1
Last updated:
There are no evaluations for Vildagliptin.